Learn About Gastroesophageal Junction Cancer

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Gastroesophageal Junction Cancer Local Doctors?
Elite
Highly rated in
12
conditions

National Cancer Center Hospital East

Chiba, JP 

Kohei Shitara is in Chiba, Japan. Shitara is rated as an Elite expert by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 12 other conditions, according to our data. His top areas of expertise are Stomach Cancer, Gastroesophageal Junction Cancer, Renal Oncocytoma, and Colorectal Cancer.

Elite
Highly rated in
26
conditions

KU Leuven University Of Leuven

BE 

Eric Van Cutsem is in Belgium. Van Cutsem is rated as an Elite expert by MediFind in the treatment of Gastroesophageal Junction Cancer. He is also highly rated in 26 other conditions, according to our data. His top areas of expertise are Gastroesophageal Junction Cancer, Pancreatic Cancer, Stomach Cancer, and Colorectal Cancer.

 
 
 
 
Learn about our expert tiers
Learn more
Elite
Highly rated in
7
conditions
Hematology Oncology
Hematology
Oncology

Memorial Sloan Kettering Cancer Center

1275 York Ave 
New York, NY 10065

Yelena Janjigian is a Hematologist Oncology specialist and a Hematologist in New York, New York. Dr. Janjigian has been practicing medicine for over 19 years and is rated as an Elite doctor by MediFind in the treatment of Gastroesophageal Junction Cancer. She is also highly rated in 7 other conditions, according to our data. Her top areas of expertise are Gastroesophageal Junction Cancer, Stomach Cancer, Esophageal Cancer, and Renal Oncocytoma. She is licensed to treat patients in New York. Dr. Janjigian is currently accepting new patients.

What are the Latest Advances for Gastroesophageal Junction Cancer?
Biweekly oxaliplatin plus S1 for Chinese elderly patients with advanced gastric or gastroesophageal junction cancer as the first-line therapy: a single-arm, phase 2 study.
A Rare Case of Primary Splenic Malignant Lymphoma Associated with Esophagogastric Junction Neuroendocrine Carcinoma(NEC).
Tired of the same old research?
Check Latest Advances
Preoperative Esophageal Decompression and Enteral Nutrition Using a W-ED Tube in Patients with Esophagogastric Junction Cancer-A Case Report.
What are the latest Gastroesophageal Junction Cancer Clinical Trials?
A Phase 1b Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer With FGFR2b Overexpression (FORTITUDE-103)
Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1/2 Study of Olaparib in Combination With Ramucirumab in Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma (10017760)